Why this chain matters

Johnson & Johnson (JNJ) has a mapped ChainSifter graph with 14 supplier links and 14 customer links. That makes it useful for investors trying to understand who benefits when JNJ performs well, and who may be exposed if demand or execution weakens.

The point is not to treat every edge as equal. The useful signal is the shape of the network: named suppliers, named customers, confidence levels, and filing language that shows where business dependence may sit.

Supplier exposure

The supplier side shows the companies and entities most directly tied to JNJ's operating base. Higher-confidence links deserve the first review because they are the relationships most likely to matter when margins, production, procurement, or delivery timelines change.

  • Protagonist Therapeutics, Inc. (PTGX) - confidence 92%.
  • Graphic Packaging Holding Company (GPK) - confidence 90%.
  • Harvard Bioscience, Inc. (HBIO) - confidence 85%.
  • AbbVie Inc. (ABBV) - confidence 85%.
  • Anika Therapeutics, Inc. (ANIK) - confidence 85%.
  • Pacira BioSciences, Inc. (PCRX) - confidence 85%.
  • Origin Materials, Inc. (ORGN) - confidence 80%.
  • Summit Therapeutics Inc. (SMMT) - confidence 72%.

Customer and demand signals

The customer side is where revenue concentration and downstream demand risk usually show up first. If a customer relationship is central to the graph, a change in that customer's spending or inventory cycle can move through the chain quickly.

  • USGOV-DEPARTMENT-OF-DEFENSE (USGOV-DEPARTMENT-OF-DEFENSE) - confidence 95%.
  • Treace Medical Concepts, Inc. (TMCI) - confidence 80%.
  • Autonomix Medical, Inc. (AMIX) - confidence 72%.
  • Genmab A/S (GNMSF) - confidence 72%.
  • Pfizer Inc. (PFE) - confidence 72%.
  • Kymera Therapeutics, Inc. (KYMR) - confidence 72%.
  • Establishment Labs Holdings Inc. (ESTA) - confidence 72%.
  • Cyclerion Therapeutics, Inc. (CYCN) - confidence 72%.

Filing evidence

ChainSifter is most useful when the map is tied back to source language. These excerpts are the evidence trail behind the graph and should be reviewed before treating a relationship as investable signal.

  • JNJ-OWNER-NORTHERN-TRUST-CORPORATION: 13F/ownership overlay lists Northern Trust Corporation; shares held 29,972,551; ownership 1.24%; value $7.3B; as of 2025-09-30.
  • JNJ-OWNER-BANK-OF-AMERICA-CORPORATION: 13F/ownership overlay lists Bank of America Corporation; shares held 28,419,787; ownership 1.18%; value $6.9B; as of 2025-09-30.
  • JNJ-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC: 13F/ownership overlay lists Geode Capital Management, LLC; shares held 57,953,747; ownership 2.41%; value $14.1B; as of 2025-12-31.
  • JNJ-OWNER-BLACKROCK-INC: 13F/ownership overlay lists Blackrock Inc.; shares held 208,781,159; ownership 8.67%; value $50.8B; as of 2025-12-31.
  • JNJ-OWNER-STATE-FARM-MUTUAL-AUTOMOBILE-INSURANCE-C: 13F/ownership overlay lists State Farm Mutual Automobile Insurance Co; shares held 31,590,952; ownership 1.31%; value $7.7B; as of 2025-12-31.

Who benefits and who is exposed

If Johnson & Johnson outperforms, the first-order beneficiaries are the suppliers with high-confidence relationships and the customers that rely on the company's output. If JNJ struggles, the exposed names are the counterparties with fewer alternate channels or relationships that appear repeatedly in the filing trail.

This is the practical use case: map the counterparties, separate confirmed relationships from weak ones, and watch for new filings that change the direction or concentration of exposure.

The most important follow-up is not simply whether a counterparty appears once. It is whether the same relationship persists across filings, appears in risk-factor language, or connects to revenue, procurement, capacity, or delivery obligations. Those are the details that turn a graph edge into investable supply chain intelligence.

What to watch

  • New or removed supplier names in future filings.
  • Customer concentration language that points to revenue dependence.
  • Confidence changes in the ChainSifter graph as new evidence is processed.